Market Research Blog – Page 15577 – New Product Development

Atopic Dermatitis Treatment Market Overview, Cost Structure Analysis, Growth Opportunities And Forecast To 2029

A new market research report by Future Market Insights on the atopic dermatitis treatment market includes global industry analysis 2014–2021 and opportunity assessment 2022–2029. The report investigates the atopic dermatitis treatment market and provides critical insights for the forecast period of 2022-2029. As per the findings of the report, the global atopic dermatitis treatment market is projected to experience significant growth over the forecast period, due to increasing prevalence, promising pipeline molecules, higher treatment compliance, increasing access to treatment medication in developing countries, favorable reimbursement policies, increasing government support for research and development, and advancing technology.

The global atopic dermatitis treatment market was valued ~ US$ 5.2 Bn in 2021, and is expected to increase at a CAGR of ~4.8% during the forecast period of 2022 and 2029.

Corticosteroids Remain the Drug of Choice

Corticosteroids are referred as the first choice of treatment for the inflammation and pain relief. These medications are known to have effects, for example, decreasing tingling, allergic reaction, swelling and redness.

Around 30 corticosteroid compounds have been licensed for atopic dermatitis treatment, of which ‘hydrocortisone’ is considered as the first. In addition, increasing innovations have resulted in the advent of topical non-corticosteroids immunomodulators and target medications, for example, immunomodulators such as pimecrolimus and tacrolimus, which in turn, is likely to fuel the growth of the atopic dermatitis treatment market. Moreover, topical corticosteroids are expected to play an important roles in the atopic dermatitis treatment.

https://www.futuremarketinsights.com/reports/sample/REP-GB-3097

North America to Offer High Sales Opportunities

Growth prospects of the atopic dermatitis treatment market are likely to be high in North America over the forecast period of 2022-2029. Factors such as, greater treatment awareness among the patient population across the United States and Canada, early adoption of novel prescriptions, advanced healthcare infrastructure, better and favorable reimbursement policies, and increasing business associations of pharmaceutical organizations with contract research organizations in developing markets will continue to propel the atopic dermatitis treatment market growth. Despite the fact that the U.S and Canada deal with heavy investment in healthcare infrastructure as well as per capita expenditure, there are increasing number of campaigns organized each year by specific establishments, for example, National Eczema Associations, the PAN Foundation, and pharmaceutical organizations, which are envisaged to work to the advantage of several market vendors.

Hospital Pharmacies – The Key Distribution Channel for Atopic Dermatitis Treatment

Sales of medication for atopic dermatitis treatment through hospital pharmacies will continue to account for relatively high share in the market, as they can stock large range of prescription medicines, including progressively specific and investigational medications. Hospital pharmacies may provide a tremendous amount of medications every day, which is distributed to wards and to intensive care units as per the patient’s prescription schedule.

Topical Drug Administration- A Preferred Mode

Topical mode of administration remains highly preferred among the patient pool of atopic dermatitis. Advent of topical non-corticosteroids immunomodulators is the major factor for the growth in the demand for atopic dermatitis treatment. As topical administration gains prominence, major corticosteroids medications are formulated as topical, in addition to their benefits over oral dosage form.

Atopic Dermatitis Treatment Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as leaders in the global atopic dermatitis treatment market. Some of the examples of key players in the global atopic dermatitis treatment market are Sanofi S.A., Galderma S.A., Allergan Plc., Novartis, Bristol-Myers Squibb, Bayer AG, Meda Pharmaceuticals Inc., Astellas Pharma, Inc., Anacor Pharmaceuticals, Inc., Regeneron Pharmaceuticals, and Valeant Pharmaceuticals International, Inc.

https://www.futuremarketinsights.com/reports/atopic-dermatitis-treatment-market/table-of-content

Clinical Oncology Next-generation Sequencing Market Overview, Cost Structure Analysis, Growth Opportunities And Forecast To 2029

Next-generation sequencing refers to the identification of the nucleotides of DNA base pairs for the diagnosis of various diseases. Oncology is one of the important applications of next-generation sequencing. It is an advanced and faster method of sequencing. Clinical oncology next-generation sequencing includes kits & reagents, services, sequencing platforms, and sequencing products. The kits and reagents used for sequencing are expected to witness significant growth in the overall market.

North America is expected to be a prominent region in the global clinical oncology next-generation sequencing market owing to the presence of well-developed healthcare infrastructure and numerous technological advancements in the region. North America and Europe are expected to witness a significant growth rate in the clinical oncology next-generation sequencing market.

Synthesis Sequencing Technology to Hold a Major Market Value Share

Based on the technology, the clinical oncology next-generation sequencing market has been segmented into pyro sequencing, sequencing by synthesis (SBS), and Single-Molecule Real-Time Sequencing (SMRT), nanopore sequencing, ligation sequencing, and reversible dye termination sequencing. Synthesis sequencing is however expected to hold a significant share in the clinical oncology next-generation sequencing market. Ion semiconductor sequencing is a method of DNA sequencing in which hydrogen ions are detected based on the polymerisation of DNA. Pyro-sequencing includes identifying the order of nucleotides in DNA based on the “sequencing by synthesis” principle, in which the sequencing is performed with the help of DNA polymerase. SBS is a technique used to determine the series of base pairs in DNA, which is also known as DNA sequencing.

There are various applications associated with clinical oncology next-generation treatment market. They include whole tumor genome sequencing, whole tumour exome sequencing, targeted tumour genome profiling, tumour transcriptome sequencing, tumour-normal comparisons, and other applications. Targeted tumor genome profiling is expected to hold a large share of the clinical oncology next-generation treatment market. On the basis of end user, the clinical oncology next-generation sequencing market has been segmented into hospital laboratories, clinical research organisations, diagnostic laboratories, and others. Clinical research laboratories are expected to hold a large revenue share in the clinical oncology next-generation sequencing market.

Apart from the factors driving the clinical oncology next-generation sequencing market, there are few factors that are likely to hinder the overall growth of the clinical oncology next-generation sequencing market, such as high costs associated with the establishment of sequencing platforms, low quality of outsourcing services, and inadequate availability of sequencing platforms in some regional markets. On the other hand, increasing biomedical research using clinical oncology, increasing government funding for life science projects, substantial decline in the prices of sequencing, and technological advancements in the field of sequencing are some of the major factors driving the growth of the clinical oncology next-generation sequencing market.

https://www.futuremarketinsights.com/reports/sample/REP-GB-9543

Tier 1 Companies Hold Nearly 3/5^th Share of Global Market Value

The report tracks some of the key companies operating in the clinical oncology next-generation sequencing market such as QIAGEN N.V., Thermo Fisher Scientific., Pacific Biosciences of California, Inc., F. Hoffmann-La Roche Ltd Oxford Nanopore Technologies, Ltd., Takara Bio, Inc., Illumina Inc., PerkinElmer Inc.and Agilent Technologies, Inc. Thermo Fischer Scientific, Oxford Nanopore Technologies Ltd., and Illumina are expected to hold a signficant share of the clinical oncology next-generation sequencing market. These first tier companies hold a share of approximately 60% in the clinical oncology next-generation sequencing market.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

https://www.futuremarketinsights.com/reports/clinical-oncology-next-generation-sequencing-market/table-of-content

Companion Animal Vaccines Market Overview, Cost Structure Analysis, Growth Opportunities And Forecast To 2029

Remarkable increase in the companion animal ownership and strong growth of development of the veterinary healthcare infrastructure collectively push the sales of companion animal vaccines in global market. Surpassing the revenues worth US$ 2.5 Bn in 2021, global companion animal vaccines market is projected to exhibit a robust CAGR during 2022 – 2029. Measurable rise in the zoonotic disease prevalence will remain a key factor fueling the demand for companion animal vaccines and drugs.

FDA approvals for novel and innovative companion animal vaccines continue to present potential growth opportunities to R&D of companion animal vaccines. For instance, Zoetis received regulatory approval for ProHeart, used for prevention of heartworm diseases caused by Dirofilaria immitis in dogs.

Key Takeaways – Companion Animal Vaccines Market Study

Attenuated live vaccines currently account for more than a third of total market value, and will continue to witness a healthy CAGR through 2029. This demand growth is attributed to their improved effectivity and enhanced long-term preventive action.
North America is witnessing lucrative market growth compared to other regions attributed to increase in the adoption rate of companion animals, increase in veterinary healthcare expenditure, and increasing awareness about pet health.
Veterinary animal hospitals and clinics offering better service support for animal care are expected to have significant market share during the forecast period
As large number of people are in close contact with canine animals as a preference for companion animal, demand will be prominent among canine species.

Rising demand for efficient monitoring, diagnosis, prevention, and treatment of various diseases among companion animals has instigated the need for novel drug development along with improved understanding of pathogenicity, immunology, and epidemiology for preventing infectious diseases at an unprecedented level.

https://www.futuremarketinsights.com/reports/sample/REP-GB-1427

Increasing R&D Investments to Widen Market Growth Prospects

Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading market players in the companion animal vaccines market. These manufacturers continue to dominate the market landscape of companion animal vaccines by investing heavily in R&D activities to develop and launch therapeutic vaccines for prevention and treatment of various animal diseases. Surge in investment for R&D of vaccines, which inhibit the growth of antibiotic-resistant organisms boosts the animal vaccines market growth.

For instance, in August 2021, Elanco invested two-thirds of the budget for food‐animal unit to develop vaccines and reduce the use of antibiotics. Moreover, rise in demand for animal vaccines led to the development of multiple new vaccines. For instance, Cevac IBron a new vaccine was launched by Ceva in February 2017 for prevention against infectious bronchitis virus (IBV) in animals.

Know More About Companion Animal Vaccines Market Report

Future Market Insight brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2029. The global companion animal vaccines is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights of the companion animal vaccines market on basis of product type (attenuated live vaccines, conjugated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines), species type (canine, avian, feline) and distribution channel (companion animal hospitals, companion animal hospitals, companion animal research institutes) across seven major regions.

About the Healthcare Division at Future Market Insights

https://www.futuremarketinsights.com/reports/companion-animal-vaccines-market/table-of-content

Medical Rehabilitation Robotics Market Outlook Cover New Business Strategy with Upcoming Opportunity 2021 to 2031

As per a recent market analysis by Future Market Insights (FMI), the global medical rehabilitation robotics market was valued at over US$ 264.0 Mn in 2020 and is projected to expand at a stupendous 15.9% CAGR over the forecast period.

Increasing development of robotic products and devices that have the ability to perform a wide array of tasks is propelling sales in the market. Surgical robots are developed for the purpose of assisting surgeons in operating on a varied range of procedures, which in turn is improving patient outcomes.

The designing and development of automated robotic models for rehabilitation and assistive services and applications have led to an advancement in disease recovery term. Rising awareness regarding the use of medical rehabilitation robotics for patients with disabilities, as well as for cognitive and behavioral disorders is spurring demand in the market.

The growth in rehabilitation therapy and integrated robotics has increased research and development activities associated with their applications in home-based settings. In comparison with clinical therapy, home therapy has the potential to augment standard care and enable a consistent treatment regime by increasing the frequency and duration of training sessions.

Carrying out rehabilitation services at home offers convenience and comfort. Growing preference for affordable, convenient, and time-saving robotic devices over other therapy devices in hospitals settings is expected to augment the growth of the market.

The development of medical rehabilitation robotics market is reliant on increasing healthcare spending, rising research and development activities, larger government-backed funding, and rising initiatives to promote the utility of rehabilitation robots

https://www.futuremarketinsights.com/reports/sample/REP-GB-14242

Key Takeaways:

Based on product type, demand in the therapeutic/assistive products is expected to account for 71.8% of the total market share in 2031, growing at a 15.4% CAGR.
In terms of extremity, the upper extremity segment is expected to hold 54.8%of the total market share by 2031.
Sales in the limb motility segment are projected to grow at a 15.9% CAGR through 2031.
In terms of patient type, the adults segment held 86.9% of the total market share in 2020, and the trend is expected to continue over the forecast period.
Applications in the neurorehabilitation segment are projected to account for a substantial share in the global medical rehabilitation robotics market.
Rehabilitation centers held the largest value share of 47.7% in 2020. However, hospitals are expected to account for 36.9% of the total market share by 2031.

“The integration of automation and assistive technology in medical equipment, along with surging demand for artificial intelligence (AI) based robotics in rehabilitation centers will continue boosting the market over the forecast period,” says an FMI analyst.

Competition Landscape

Leading players operating in the market are investing in acquisitions, mergers, expansion, and the development of an extensive clinical pipeline to improve sales in the market. Besides this, players are expandingtheir product portfolios to increase their consumer base. For instance:

In October 2021, Fourier Intelligence was selected and awarded the Top 4 Leading Rehabilitation Technology Enterprise by KPMG and the China Association of Non-Public Health Institutions, co-organized by the Health Sector Strategy at an event that was held in Shanghai.
In December 2020, Anthrtonix DANA, a telehealth tool by AnthroTronix, was used at the Johns Hopkins Hospital to identify and monitor cognitive deficits and recovery of COVID-19 patients.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the medical rehabilitation robotics market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on the Product – (Exoskeletons and Therapeutic/ Assistive), Extremity- (Upper Extremity and Lower Extremity), Therapy Type (Limb Mobility, Gait and Sensory), Patient Type (Adult and Paediatric), Application (Neurorehabilitation, Physical Rehabilitation and Others) and End User (Hospitals, Wellness Centers, Rehabilitation Centers and Homecare) across seven key regions of the world.

Future Market Insights’ Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.

About the Healthcare Division at Future Market Insights

https://www.futuremarketinsights.com/reports/medical-rehabilitation-robotics-market/table-of-content

Cold Disposable Biopsy Forceps Market Outlook Cover New Business Strategy with Upcoming Opportunity 2021 to 2031

According to a recent study by Future Market Insights (FMI), the cold disposable biopsy forceps market is expected to witness high growth during the forecast period. The market value is slated to increase from US$ 505.1 Mn in 2020 to over US$ 1.2 Bn by 2031 at 8.4% CAGR over the forecast period (2021-2031).

The cold disposable biopsy forceps market will register high demand due the rising prevalence bronchitis and gastrointestinal disorders such as IBD and GERD among the geriatric population and the increasing awareness towards endoscopic procedures. There is also a rise in the adoption of disposable biopsy forceps that to be reliable for test sampling expects to gain popularity.

At present, the minimally-invasive technology, with the endoscope system at the core, has been extended to obstetrics, general surgery, otolaryngology, gynecology, thoracic surgery, urology, pediatrics, and other departments. Minimally-invasive endoscopic technology has become an indispensable technology for the diagnosis and treatment of chronic diseases associated with breathing, digestion, urology, otolaryngology, and so on.

With the rising demand for endoscopic minimally-invasive technology and continuous improvement in endoscopic processing technology, endoscopic applications have become prominent in almost all departments. The growing demand for diagnosis and endoscopic treatment is expected to further boost the demand for cold disposable biopsy forceps.

Numerous recent technological advances are becoming available to endoscopists. An abundance of new imaging modalities is expected to facilitate early detection of chronic disorders and other pathological entities. Most of these techniques remain investigational and are currently in clinical trials to determine patient benefits.

Companies are expanding their product lines by manufacturing different types of products for a wide range of applications.

For instance, Micro-Tech Endoscopy is mainly engaged in the R&D, manufacturing, and sales of minimally-invasive medical devices, in line with its mission of supporting clinicians with technology and innovation.

https://www.futuremarketinsights.com/reports/sample/REP-GB-14240

Key Takeaways from Cold Disposable Biopsy Forceps Market Study

Oval cup forceps gained popularity and their sales are expected to grow at a CAGR of 8.8% during the forecast period.
2.8 mm diameter have sharpened cups whch ensure superior cutting performance and lead to fewer artefacts and less bleeding. The segment is therefore expected to account for a share of 24.9% in 2021.
2300 mm length forceps has precise jaws, no tearing and cause small wound. The segment accounted for the highest share of 37.9% in 2021.
Upper GI Endoscopy dominated the application segment with the highest market share of 24.9% in 2021.
Hospitals accounted for the largest share of around 42.0% in 2021 and will remain the end user in the market.

“High prevalence of conditions such as IBD and GERD and growing demand for minimally invasive endoscopic procedures are set to boost the demand for cold disposable biopsy forceps market over the next decade,” says the Future Market Insights analyst.

Who is winning?

The key players are focusing on acquisitions and partnerships with small players and suppliers to increase their market presence. Besides this, they are adopting various strategies to expand their footprint. For instance:

iIn April 2018, Boston Scientific Corporation closed its acquisition of NxThera. The company developed a minimally-invasive therapy the Rezūm system, for patients suffering from symptomatic benign prostatic hyperplasia. With the completion of the acquisition, NxThera became a part of Boston Scientific’s urology and pelvic health business. Moreover, the manufacturers are focusing on research and development activities for developing cold disposable biopsy forceps for various research applications.

In july 2020, ChargePoint and STERIS collaborated to develop a fully validated sterile transfer solution to offer a unique and integrated solution for sterile product transfer.

Some of the leading players in the cold disposable biopsy forceps market include but are not limited to Olympus Corporation, Boston Scientific Corporation, STERIS, CONMED Corporation, Cook Medical, Micro-Tech Endoscopy, Anrei Medical and other companies.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global cold disposable biopsy forceps market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The cold disposable biopsy forceps market is segmented into six parts based on product (oval cup, oval cup with needle, alligator jaw, alligator jaw with needle) based on diameter (1.2mm, 1.8mm, 2.0mm, 2.4mm, 2.8mm, 3.7mm) based on length (1150 mm, 1550 mm, 2300 mm), based on application (enteroscopy, upper GI endoscopy, lower GI endoscopy, bronchoscopy and others, based on end user (hospitals, ambulatory surgical centers specialty clinics, diagnostic laboratories, and cancer research institutes) and across seven major regions.

About the Healthcare Division at Future Market Insights

https://www.futuremarketinsights.com/reports/cold-disposable-biopsy-forceps-market/table-of-content

Green Banana Flour Market is growing with a healthy CAGR of 5.2% during the forecast period of 2021 – 2031

Alternative flours are gaining traction especially since they are known to offset disadvantages of traditional whole wheat or wheat flour. According to a new study by Future Market Insights (FMI), the green banana flour market is set to reach US$ 435.7 Mn by the end of 2021. The rising demand for improved nutritional value in food along with new flavors, textures and aromas, among consumers are enabling sales in the market.

Green banana flour is trending as a gluten-free ingredient for the food industry, which in turn is creating opportunities for key players to capitalize on. Changing buyers values have led to seek more nutrition from natural and high-quality food sources with clean labels. With consumers seeking healthier options, it is seen that these products have appeal across a broad spectrum of potential buyers.

Driven by consumers’ piqued interest, green banana flour is now being made available in a particular flavor or a combination of other fruit flavors. According to FMI, the demand for conventional green banana flour is remarkably high and it is expected to account for over 95% sales in 2021.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13028

Key Takeaways from the Green Banana Flour Market Study

Green banana flour market is expected to register 4.6% Y-o-Y growth in 2021
The U.S. will emerge as a highly attractive market, accounting for over 85% of sales in North America in 2021
Exhibiting above 6% Y-o-Y growth in 2021, the U.K. will emerge as an attractive market for green banana flour within Europe
The demand from Germany and France too is forecast to rise at an impressive pace
Within East Asia, China will exhibit strong growth, followed by Japan and South Korea

“The food industry is actively developing palatable products, allowing people with allergies to gluten and wheat enjoy breads, baked goods, pasta, and other food items made using processed flour. This has been one of the crucial drivers of green banana market. Green banana flour has a very mild raw banana taste; it also has a lighter wheat flour-like texture and needs around 25 % low volume, making it a strong wheat flour substitute, which will continue aiding sales through the forecast period,” said a lead analyst at FMI.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13028

Quality Concerns Pertaining to Food Enabling Green Banana Flour Sales

Rising concerns regarding quality of food products, along with growing awareness about health & wellbeing, are pushing consumers to increasingly opt for healthy and organic products Green banana powder is being sold in its retail format for household purposes in large quantities. Growing purchasing power and increased opportunities for women in the workforce have resulted in less time for home cooking, and higher demand for processed or prepared foods. As a result, there is a rise in consumer expenditure on grocery retail and food.

Not only is it a must for those with gluten allergies to use substitute flours, but it’s also a perfect choice for many recipes to add nutrients. Green banana flour is lower in calories than all-purpose flour at only 100 calories per 1⁄4 cup, which essentially helps minimize the total calorie count without losing flavour or texture.

Who is winning?

Rising inclination towards vegetable and fruit flours across various regions is fuelling the demand for green banana flour. Manufacturers across the globe are are investing heavily to update their inventories with green banana flour products to cater to the growing demand.

For instance, Zuvii specializes in the production and marketing of gluten-free food ingredients for both retail and commercial sectors. The company offers products such as gluten-free banana flour, pancake and waffle mix, brownie mix, chocolate cake mix, vanilla cake mix, and bundles. The green banana flour produced by the company is claimed to be starch free, and good for the gut due to its probiotic nature.

Some of the key players in green banana flour market are are International Agriculture Group, Made’s Green Banana Flour Co., Kanegrade Ltd., Natural Evolution Limited, Slingan Pty Ltd., NOW Health Group, Inc, NuNatural Inc, Zuvii, Pereg Gourmet Natural Foods, M-Pak, Banatone Food Industries, Stawi Foods and Fruits Limited, Vinayak Ingredients (INDIA) Pvt. Ltd., Hearthy Foods, Saipro Biotech Private Limited, Paradise Fruits, Royal Nut Company, Absolute Organic, KADAC Pty Ltd.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-13028

Get Valuable Insights into green banana flour market

Future Market Insights, in its new offering, provides an unbiased analysis of the green banana flour market presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the green banana flour market based on product type (Organic Green Banana Flour and Conventional Green Banana Flour), by process (Freeze Dried Process, Spray Dried Process, Sun Dried Process and Others), by Sales channel (Direct Sales and Indirect Sales), and by application (Household, Food Industry, Beverages, Pet Food & Feed Industry).

Odour Control System Market Competitive Growth Strategies Based on Type, Applications, End User and Region

The newest market research study by Future Market Insights on odour control system includes the global industry analysis for 2014–2018 and market forecast for 2019–2029. The study observes the odour control system market and offers detailed perceptions for the forecast period of 2019-2029. According to the analysis and study done in the report, the global odour control system market is anticipated to observe prominent progress, due to increasing adoption in the chemical industry.

The odour control system market is estimated to be valued at ~ US$ 1 Bn in 2019, and is projected to increase by ~ 5% CAGR during the forecast period of 2019-2029.

The odour control system market has a high potential to grow in regions such as Asia Pacific Excluding Japan (APEJ) and North America. Significant innovations with incorporation of advanced technologies meeting regulations are expected to emerge as a product differentiator in the odour control system market.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-849

Installation of hybrid odor control systems and demand for advanced and cost-effective odour control system from various industrial and government entities have increased significantly. This growing demand for progressive products generates pressure on manufacturers to deliver technologically-advanced and unique product offerings. Thus, technological advancements have led to noteworthy investment in research and development by manufacturers. Manufacturers in the odour control system market are constantly focusing on developing unique technologies, which help them differentiate their products and earn a competitive edge.

Odour control systems play a crucial role in wastewater and solid waste treatment facilities. Individual odour control systems can be installed at various locations in a single wastewater treatment facilities, or a centralize system could be installed for low capacity plants. Increasing investment for the effective and efficient waste management, establishment of new plants and capacity increase of existing facilities, and also growing intolerance towards odours, are factors expected to increase the demand for odour control systems in near future.

Japan to Provide Noteworthy Growth Opportunities for Manufacturers

The ongoing technological advancements and progression in investment for the storm water management projects and wastewater treatment facilities are expected to grow significantly over the forecast period. Odour control system manufacturers are focusing more on improving their market structures and offerings in the region. Emphasis on trade balance and increasing production by strengthening the manufacturing sector is currently the prime motive of the government in Japan. Also, the adoption of ‘best available technique’ is prominent in the country, which is likely to propel the demand for advanced odour control system.

Japan has large installed base of odour control systems which are likely to get regular up gradation and replacements. Considering the average life of the odour control systems and the install base, the market in Japan is estimated to surge in next few years.

For the global odour control system manufacturers, Japan is projected to be a prominent market throughout the forecast period, owing to the increasing consumption and production of odour control systems across several industries.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-849

Chemical & Petrochemical Industry to Capture Prominent Share

The division of the global odour control system market has been done on the basis of application, along with six regions.

High application potential of odour control system is identified in chemical & petrochemical industry. These industries produce odorous compounds such as hydrogen sulfide, ammonia,mercaptansand several others.The air contains odorant molecules, which must be treated to avoid corrosion and to comply with environment regulations, hence mandating the use of odour control systems in chemical & petrochemical industries.
Waste treatment and disposal plants are a major source of odour emission. The effluents and vapors coming from these sources are of different and unpredictable composition. Hence, it becomes a necessity to install a combination of odour controls systems at these locations, thereby potentially influencing the market growth.

Odour Control System Market: Vendor Insights

The global odour control system report emphasizes on some of the principal industry players. Some of the key players include Babcock & Wilcox Enterprises, Inc., CECO Environmental., Anguil Environmental Systems, Inc., Evoqua Water Technologies LLC, Scotmas Limited, Ecolab Inc., Tholander Ablufttechnik GmbH,among others.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-849

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

India Alcohol Market is expected to reach US$ 68 Bn by the end of 2026, Says FMI Analyst

The number of alcohol consumers in India continues to rise on the account of rising urban population. Consuming alcoholic beverages has become a customary tradition for a majority of people residing in India’s urban cities. Changing lifestyles and increasing incomes are compelling them to consume alcohol on a frequent basis. Future Market Insights recently published its study on India’s alcohol market, which estimated that more than INR 2.5 trillion worth of alcohol was consumed in 2016. The study further projected that consumption of alcohol in India is less likely to decline in the years to come. By the end of 2026, more than 14 billion litres of alcohol will be sold across India.

According to the report, revenues amassed from sales of alcohol in India will soar vigorously at 7.4% CAGR, and reach INR 5.1 trillion value by the end of 2026. In terms of volume, India’s alcohol consumption in 2016 has been estimated to have surpassed 8 billion litres and will grow at 5.5% CAGR in the due course of forecast period. An in-depth analysis on India’s alcohol distribution indicated that just above three-fourth of alcohol consumed in the country is government controlled. In 2016, alcohol distributed in India through open market sales made revenues worth over INR 400 billion. Meanwhile, about 550 million litres of alcohol was auctioned in India by the end of 2016.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-IN-201

India’s Alcohol Market: Report Highlights

Nearly two-third of India’s alcohol revenues will be accounted by sales of Indian-made foreign liquor (IMFL)
In 2016, more than 1,800 million litres of strong beer was consumed in India
By the end of 2026, white wine sales in India will have brought in an estimated INR 16.8 billion in revenues
Revenues amassed from sale of country liquor in India will have soared at 5.5% CAGR
Whisky will be the most-preferred type of alcohol in India, while sales of white spirits will grow at more than 11% CAGR

Key findings of the report, titled “Alcohol Market: India Industry Analysis and Opportunity Assessment, 2016-2026,” projected that Southern and Western states of India will continue to contribute to more than 80% of alcohol revenues through 2026. Bangalore’s SAB Miller India Ltd. and United Spirits Ltd., and Mumbai-based Tilaknagar Industries Ltd. and Allied Blenders & Distillers Pvt. Ltd. are key players partaking in the growth of India’s alcohol market.

Meanwhile, the consumption of alcohol will witness a considerable dip in India’s northern and eastern zone. Even still, a majority of alcohol manufacturers & suppliers in India are originating from New Delhi. Companies such as Carlsberg India Pvt. Ltd., SOM Distilleries & Breweries Group, Radico Khaitan Limited, Globus Spirits, and Jagatjit Industries Ltd. are based in and around the country’s capital. Shimla’s Mohan Meakin Ltd. and Daman’s Khemani Group are also recognised as some of the leading alcohol manufacturer in India.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-IN-201

Over 90% of Indian Alcoholics are Men

Among every ten alcohol consumers in India, nine of them will most probably be men; leaving a slight chance that the tenth one is a woman. With more than 90% stake in India’s alcohol revenues, the country’s men will be offering over INR 4.7 trillion for consuming alcohol by the end of 2026. Likewise, Indian women are also likely to increase their contribution to the Indian alcohol market. During the forecast period, revenues accounted by sales of alcohol to Indian women will have soared at the fastest pace, registering a stellar CAGR of 8.6%.

Consumption of alcohol containing molasses as key ingredients will remain higher in India. Grains will also serve to be a preferred raw ingredient used for producing alcohol in India. Although, production of alcohol through agricultural produce such as fruits & vegetable will remain negligent till the end of 2026. The report also anticipates that consumers will be more inclined towards buying Indian-made liquor – regardless of it being a foreign or Indian brand. Consumption of foreign liquor bottled in India is also likely to grow, but showcasing a marginal degree of increment.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-IN-201

About Future Market Insights (FMI)

Plant-based Snacks Market is expected to reach a Valuation of US$ 73.61 Bn by the end of 2028, finds Future Market Insights

The global plant-based snacks market size stood at US$ 34.69 Bn in 2019. Rising at a CAGR of 8.7%, the market is forecast to reach US$ 73.61 Bn by the end of 2028, finds Future Market Insights in a report, titled “Plant-based Snacks Market: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2028.” The report discovers hidden opportunities in the market to empower companies irrespective of their sizes. It compiles in-depth information on prevailing trends and regulatory policies that are likely to affect the market dynamics. It also contains detailed information about competitive trends sweeping the market. The report covers a detailed market analysis intended to help market players determine their corporate strategies with precision and accuracy.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5399

Some of the key takeaways from the report are:

Rising awareness about health and wellness creates incredible growth opportunities
North America forecast to hold dominance over the forecast period, but Asia Pacific excluding Japan is projected to show more impressive growth.
Besides health consciousness among consumers, availability of plant-based snacks in diverse flavours will aid the expansion of the overall market.
On the flip side, high price of plant-based products may pose threat to the market.
Never mind this, the rising demand for meat-substitutes will stoke growth opportunities for the market in the coming years.

“Asia Pacific is home to some of the leading food producers, importers, and exporters in the world. The region offers abundant opportunities for the market’s growth, as it is also home to some of the most populous countries in the world,” said a lead FMI analyst.

Excessive Snacking Resulting from Increasingly Hectic Lifestyle Fuels Demand

Fast-paced lifestyle of consumers across the globe leaves little scope for traditional three course meal with families. This is attributable to increasing industrialization and rapid urbanization. Frequent-snacking has struck consumers hard. It is no surprise that a majority of them involuntarily turn to round-the-clock snacking to gratify hunger. This did provide an opportunity for manufacturers to rejoice but did not carry good news for consumers. Their snacking habit, in addition to unhealthy lifestyle, amplified the prevalence of various chronic ailments such as cardiovascular disorders and diabetes. While it is difficult to tone down fast-pace life, consumers nowadays have become more conscious about their health and wellness. Therefore, the demand for plant-based snacks is evidently high. In general, there is willingness among consumers to spend on snacks that are nutritious and contain natural ingredients.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5399

Increasing Food Safety Concerns Tips Scale in Favour of Healthier Plant-based Snacks

Most dairy-based products use antibiotics and hormones. Rising concerns pertaining to the safety of dairy-based products are causing consumers favour safer alternatives such as plant-based products. An increasing number of consumers are avoiding dairy-based products and switching to plant-based alternative, including snacks.

Consumers are Swayed Away by Reports of Animal Cruelty and News about Maltreatment in Food Industry

Consumers around the world have become more sympathetic and sensitive towards animals. The conditions in which they are raised and harvested are not necessarily compassionate. Increasing focus on animal welfare is one of the primary factors swaying customers away from animal-based products to plant-based alternative. For instance, cows often undergo genetic manipulations and are administered with bovine growth hormones so that they produce a certain volume of milk every year. News about atrocities on animals is spreading like wildfire. As a result an increasing number of consumers globally are opting for plant-based snacks instead of dairy products.

Who is Winning?

The demand for plant-based snacks, resulting from changing eat-habits of consumers, will continue rising through the forecast period. Market players are therefore expected to witness increasing demand. In order to stay relevant in the global plant-based snacks market and gain competitive edge, some of the leading players are focusing in product innovations. For instance, they are experimenting with flavours, ingredients, and various combinations to gain traction. Some of the larger companies are acquiring smaller companies with promising outlook to expand their footprint and product portfolio.

Some of the leading companies operating in the plant-based snacks market are General Mills Inc, Maple Leaf Foods Inc., The Unilever Group (Growing Roots), Blue Diamond Growers, Inc., Nestlé, Primal Spirit Foods, Inc., Louisville Vegan Jerky Company, Eat Natural, Eat Real, Green Park Snacks Ltd (Hippeas), Quorn, Soul Sprout, Oumph, Upton’s Naturals, and Drink Eat Well, LLC (Hilary’s).

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-5399

Get Valuable Insights into Plant-based Snacks Market

Future Market Insights, in its new report, presents an unbiased analysis of the global plant-based snacks market, covering historical demand data and forecast figures for the period between 2019 and 2028. The study divulges compelling insights into growth witnessed in the market. In terms of source the market is categorized into meat alternative snacks, cereals/ grain based snacks, plant-based salted snacks, plant-based snack bars, fruit and nut snacks and others. On the basis of nature, the market is split between organic and conventional. In terms of format, the market is bifurcated into savoury and sweet. By packaging, it covers pouches, wrapper, bags, and tins. In terms of sales channel, the market can be segmented into food service provider, hypermarkets/ supermarkets, specialty stores, convenience stores, small groceries, and online retail. Regionally North America, Latin America, Western Europe, Eastern Europe, APEJ, MEA, and Japan constitute the key segments in the global plant-based snacks market.

About Future Market Insights (FMI)

Herbal Tea Market Size by 2026: Global Demand and Regional Analysis

In today’s world the second largest consumed beverage is tea after water. Herbal Tea is the new emerging trend among the health conscious people. Herbal tea is made from infusion or by boiling the herbs, spices or dissolved chemicals from herbal or plant material in water to extract the active herbal ingredients. These herbal teas are taken from eminent true teas like black, green, yellow, etc. It is made from the cured leaves of tea plant Camellia Sinensis and also from decaffeinated tea. Like beverages, herbal tea can be presented as hot or cold. Herbal tea can be consumed as iced tea too by chilling it with ice cubes in summer season. Herbal tea can be consumed with sugar or honey, with or without fruit juices for health conscious people and diabetic people. Drinking herbal tea cuts down caffeine intake and helps in reducing sugar level. There are various types of herbal teas like ginger, ginkgo biloba, ginseng, hibiscus, jasmine, rosehip, mint, chamomile, etc.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2513

Herbal Tea Market Segmentation:

Herbal tea market is segmented on the basis of raw material type, flavor type, packaging type, product type and region. On the basis of raw material type herbal tea market is segmented as black tea, green tea and yellow tea. Out of these segments black herbal tea market share is less as compared to green herbal tea which is recognized as nutritious and healthier to the young generation especially. Green herbal tea provides wider spectrum of varieties and new product developments in relation to black herbal tea. On the basis of product type herbal tea is segmented as instant premixes, liquid and powdered RTD and syrups. From these given segments powdered instant premixes are being widely used as it is easy to carry anywhere and is favorable in every season. Liquid herbal tea is consumed on a large scale as a refreshing drinks which contributes a rapid growth in herbal tea market. The syrup includes sugar and herbal tea extracts which is mostly used by the young generation benefiting to increase the market share of herbal tea market.

Herbal tea market is segmented as flavor types like lemongrass, peppermint, fruit, hibiscus, ginger and chamomile. Lemongrass herbal tea is mostly consumed worldwide. Peppermint herbal tea relieves muscle spasms and is used widely. Herbal tea made from chamomile flowers can be helpful in insomnia. Herbal tea is also segmented on the basis of packaging like can packaging, carton packs, herbal tea bags, herbal tea paper pouches and loose tea, which covers herbal tea market share and is expected to expand widely in the forthcoming years.

Herbal Tea Market: Regional Outlook

The herbal tea market is segmented on the basis of regions like North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East and Africa. Japan, Eastern Europe and North America are in increasing demand for herbal tea, which is the

potential market and established markets for herbal tea due to its anti-aging properties. New herbal tea brands are appearing weekly with the increasing demands for processed foods and ready to drink beverages on a large scale and is expected to scroll robust CAGR in forthcoming years.

Request Brochure of Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2513

Herbal Tea Market: Drivers

Increased population, disposable income, growing health awareness of the consumers and the ongoing wellness trends are some of the driving factors influencing to enlarge the herbal tea market in the anticipated years. Lipton Herbal Tea is mostly used for the treatment of liver problems by supporting it in the release of toxins from the body. In many cases the frontier between enjoyment and medicinal purposes have shifted to obscure. These trends in turn initiated opportunities for the herbal tea extract producers to contribute the functional food and neutraceutical market sectors with new ingredients.

Herbal Tea Market: Key Players

The key players operating in herbal tea market consists of AB Food and Beverages, Tata Global Beverages, Martin Bauer Group, Nestea, Unilever, Buddha’s Herbs, Green Earth Products Pvt Ltd, Mothers Parkers Tea and Coffee Inc., Global Herbitech, Rooibos and Typhoo India.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-2513

About Future Market Insights (FMI)